About the Authors

Giuseppe Balistreri

Contributed equally to this work with: Giuseppe Balistreri, Johanna Viiliäinen

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Johanna Viiliäinen

Contributed equally to this work with: Giuseppe Balistreri, Johanna Viiliäinen

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Mikko Turunen

‡ MT and RD also contibuted equally to this work.

Affiliation Genome-Scale Biology Program, Research Programs Unit and Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland

Raquel Diaz

‡ MT and RD also contibuted equally to this work.

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Lauri Lyly

Affiliation Genome-Scale Biology Program, Research Programs Unit, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

Pirita Pekkonen

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Juha Rantala

Affiliation VTT Medical Biotechnology, Turku, Finland

Krista Ojala

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Grzegorz Sarek

Current address: London Research Institute, Cancer Research UK, Clare Hall Laboratories, South Mimms, United Kingdom

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Mari Teesalu

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Oxana Denisova

Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

Karita Peltonen

Affiliation Centre for Drug Discovery, University of Helsinki, Helsinki, Finland

Ilkka Julkunen

Affiliation Department of Virology, University of Turku and National Institute for Health and Welfare, Turku, Finland

Markku Varjosalo

Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

Denis Kainov

Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

Olli Kallioniemi

Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

Marikki Laiho

Affiliations Centre for Drug Discovery, University of Helsinki, Helsinki, Finland, Department of Radiation Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

Jussi Taipale

Affiliation Genome-Scale Biology Program, Research Programs Unit and Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland

Sampsa Hautaniemi

Affiliation Genome-Scale Biology Program, Research Programs Unit, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

Päivi M. Ojala

p.ojala@imperial.ac.uk

Affiliations Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland, Foundation for the Finnish Cancer Institute, Helsinki, Finland, Section of Virology, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom

Competing Interests

The authors have declared that no competing interests exist

Author Contributions

Conceived and designed the experiments: GB JV MTu LL JR KO RD GS MTe OD DK JT SH PMO PP. Performed the experiments: GB JV MTu LL JR KO RD GS MTe OD. Analyzed the data: GB JV MTu LL JR GS MTe OD DK JT SH PMO. Contributed reagents/materials/analysis tools: KP IJ MV DK OK ML JT SH PMO. Wrote the paper: GB JV MTu LL JR GS KP ML PMO.